Inclusion Criteria:  ①Inpatients diagnosed with non-small cell lung cancer or colorectal cancer; ②Bevacizumab biosimilars or original drugs were used for treatment during the study period.  Exclusion Criteria:  ①Age<18 years old; ②Person who has used bevacizumab within six months.